- Filed
- Nov 3, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 29, 2025 | 48.19M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 48.36M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 48.25M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 48.13M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 48.04M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $44.62M |
| Capex restated | Q3 2025 · Sep 30, 2024 | $1.07M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$9.08M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $39.3M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $98.17M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $60.85M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $249.24M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $262.04M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $252.82M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $268.68M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $292.38M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $460.1M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $80.16M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $114.51M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $87.51M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $131.21M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $199.01M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $188.59M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $336.75M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $384.03M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.26 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.09 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.50 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$3.99 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.26 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.09 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.50 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$3.99 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $5.16M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $14.99M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $6.78M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $108.83M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$12.62M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$4.3M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$24.04M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$191.85M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$9.01M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$45.93M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$6.13M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$110.96M |
| Revenue | Q3 2025 · Sep 30, 2025 | $14.8M |
| Revenue | Q3 2025 · Sep 30, 2025 | $46.8M |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $17.05M |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $48.42M |